TheNote.app
Science Magazine | AAAS: Science Translational Medicine

Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers | Science Translational Medicine

NR2F2 modulates the ER cistrome, coregulator interactions, and chromatin accessibility to promote endocrine resistance in ER+ breast cancer.
favicon
science.org
science.org
Image for the article: Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers | Science Translational Medicine
RSS Hunter
© 2015-2025, TheNote.app
· Privacy Policy · Terms & Conditions · Contact · Android iOS MacOS